TIAA CREF INVESTMENT MANAGEMENT LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 83 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2019$565,000
+67.2%
107,855
+0.4%
0.00%
Q4 2018$338,000
-74.3%
107,387
-50.6%
0.00%
Q3 2018$1,316,000
+105.3%
217,412
+79.8%
0.00%
Q2 2018$641,000
+222.1%
120,948
+64.5%
0.00%
Q1 2017$199,000
-9.1%
73,534
-2.8%
0.00%
Q4 2016$219,000
-42.8%
75,667
-18.8%
0.00%
Q3 2016$383,000
-14.7%
93,219
-34.3%
0.00%
Q2 2016$449,000141,9840.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2016
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders